Life Healthcare’s enlarged international business accounted for nearly a quarter of group revenue in the year to end-September, from just 7% previously, chief financial officer and acting CEO Pieter van der Westhuizen said on Tuesday. The private-hospital operator bought 94% of UK-based Alliance Medical Group in November 2016 and increased its shareholding in India’s Max Healthcare Institute in August 2017 to 49.7%. These deals helped the group to grow revenue by 27% to R20.8bn in its 2017 financial year. However, normalised earnings per share fell 45%, partly due to one-off items related to the Alliance Medical acquisition and the further impairment of the group’s investment in Polish company Scanmed. Life Healthcare shares closed 6.8% up at R26 on Tuesday. The firm said while its UK business continued to benefit from a growth in scan volumes, it was "experiencing increased competition on the mobile diagnostic business as more capacity is added to the market". However, it had been ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now